We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Substantial gains in order intake and sales revenue Overproportionate increase in profit Continued high growth momentum for the Bioprocess Solutions Division; for Lab Products...
Sartorius, a leading international laboratory and pharmaceutical equipment provider, closed the year 2012 with double-digit sales growth and increased its earnings by a good 20%. At the...
Sartorius, ein international führender Labor- und Pharmazulieferer, hat das Jahr 2012 mit zweistelligem Umsatzwachstum abgeschlossen und seinen Ertrag um gut 20% gesteigert. Auf der...
Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, grew dynamically again in fiscal 2012 and further increased its profitability...
Sartorius, a leading international laboratory and pharmaceutical equipment provider, successfully closed the first nine months of 2012, with substantial gains in order intake...
Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, successfully closed the first six months of 2012, with substantial gains in order...
Sartorius AG (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, will be admitted to the TecDAX technology index. This was announced yesterday...
Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, started off fiscal 2012 with substantial gains in order intake, sales revenue and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions